Stay updated on Trivalent P2-VP8 Vaccine Clinical Trial
Sign up to get notified when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.

Latest updates to the Trivalent P2-VP8 Vaccine Clinical Trial page
- Check6 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new site revision (v3.4.2) was added and a government-funding operating-status notice was removed. These changes are cosmetic and do not affect the study details or how the page is used.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding/operating status notice. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a Show glossary option and updated metadata labels to reflect Last Update Submitted that Met QC Criteria and Revision: v3.4.0. The older lowercase variant 'met QC Criteria' and the previous revision tag (v3.3.4) were removed/replaced.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Gauteng as a location under the Locations section. Removed the prior Gauteng Locations entry and the HHS Vulnerability Disclosure link; updated page revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Trivalent P2-VP8 Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.